Millrace Asset Group Inc. Has $1.70 Million Stock Position in Viemed Healthcare, Inc. (NASDAQ:VMD)

Millrace Asset Group Inc. raised its stake in Viemed Healthcare, Inc. (NASDAQ:VMD) by 13.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 231,322 shares of the company’s stock after acquiring an additional 27,084 shares during the quarter. Viemed Healthcare comprises 1.7% of Millrace Asset Group Inc.’s holdings, making the stock its 24th largest position. Millrace Asset Group Inc.’s holdings in Viemed Healthcare were worth $1,696,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the stock. Evernest Financial Advisors LLC acquired a new position in shares of Viemed Healthcare in the second quarter valued at about $66,000. Perkins Coie Trust Co bought a new stake in Viemed Healthcare in the 3rd quarter valued at about $73,000. Victory Capital Management Inc. grew its position in shares of Viemed Healthcare by 21.1% during the 2nd quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock worth $84,000 after purchasing an additional 2,226 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of Viemed Healthcare during the third quarter worth approximately $89,000. Finally, Price T Rowe Associates Inc. MD acquired a new stake in shares of Viemed Healthcare in the first quarter valued at approximately $97,000. 74.24% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Nitin Kaushal sold 30,000 shares of Viemed Healthcare stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $9.56, for a total transaction of $286,800.00. Following the sale, the director now directly owns 126,843 shares in the company, valued at $1,212,619.08. This trade represents a 19.13 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Randy E. Dobbs sold 36,261 shares of the business’s stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the completion of the sale, the director now directly owns 107,706 shares in the company, valued at approximately $999,511.68. This represents a 25.19 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 20.00% of the company’s stock.

Viemed Healthcare Trading Down 1.1 %

Shares of VMD stock opened at $8.65 on Tuesday. The stock has a 50 day simple moving average of $8.51 and a 200 day simple moving average of $7.57. Viemed Healthcare, Inc. has a 1 year low of $6.21 and a 1 year high of $10.44. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. The stock has a market cap of $336.83 million, a P/E ratio of 32.04 and a beta of 1.43.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The business had revenue of $58.00 million during the quarter.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.